← Back
$KURA All transactions

Kura Oncology, Inc.

▼ SELL 10b5-1 Plan

$ Value

$10K

Shares

1,558

Price

$6

Filed

May 19

Insider

Name

FORD KATHLEEN

Title

Chief Operating Officer

CIK

0001785406

Roles

Officer

Transaction Details

Transaction Date

2025-05-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

21,367

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024. | 1,558 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. | This transaction was executed in multiple trades at prices ranging from $6.27 to $6.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing Info

Accession No.

0000950170-25-074659

Form Type

4

Issuer CIK

0001422143

FORD KATHLEEN's History

Date Ticker Type Value
2026-01-27 KURA $15K
2026-01-02 KURA A $0
2026-01-02 KURA A $0
2025-11-14 KURA $77K
2025-11-13 KURA A $0
2025-09-29 KURA $62K
2025-09-27 KURA A $0
2025-05-19 KURA $10K

Other Insiders at KURA (90d)

Insider Bought Sold Last
WILSON TROY EDWARD
President and CEO
2026-03-23
FORD KATHLEEN
Chief Operating Officer
$15K 2026-01-27
Bair Teresa Brophy
Chief Legal Officer
$95K 2026-01-27
DOYLE THOMAS JAMES
SVP, Finance & Accounting
$60K 2026-01-27
Powl Brian T.
Chief Commercial Officer
$54K 2026-01-27
Leoni Mollie
Chief Medical Officer
$69K 2026-01-27
Burrows Francis
Chief Scientific Officer
$11K 2026-01-27